1 not yet recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Gemzar: new trials by email Literature Review of Gemzar trials Research Report on Gemzar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) Pembrolizumab, Cisplatin, 5-Fluorouracil - Neoplasm Malignant, Gastric Neoplasms | Phase 4 | Not yet recruiting | Merck Sharp & Dohme LLC | 150 | 2026-11-06 | 2026-09-03 |
| Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC Sequential and maintenance icotinib, Maintenance icotinib - EGFR Positive Non-small Cell Lung Cancer, Adenocarcinoma | Phase 4 | Unknown | Betta Pharmaceuticals Co., Ltd. | 100 | 2014-07-01 | 2014-07-18 |
Adenocarcinoma (1) · Neoplasms (1) · Stomach Neoplasms (1) · Uterine Cervical Neoplasms (1)
Betta Pharmaceuticals Co., Ltd. (1) · Merck Sharp & Dohme LLC (1)
China (1)
Xiaohua Hu, MD (1)